{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:55:26Z","timestamp":1781535326002,"version":"3.54.5"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,15]]},"DOI":"10.7759\/cureus.110890","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:35:46Z","timestamp":1781534146000},"source":"Crossref","is-referenced-by-count":0,"title":["Stage IV Rectal Adenocarcinoma After Negative Multitarget Stool DNA-Fecal Immunochemical Test in a Symptomatic Patient: Misapplication of a Screening Test in a Diagnostic Context"],"prefix":"10.7759","author":[{"given":"Yazan","family":"Omari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Nohomovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dima","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Sorser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel RL","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023, 73:17-48. 10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4417","article-title":"Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"325","author":"Lin JS","year":"2021","unstructured":"Lin JS, Perdue LA, Henrikson NB, Bean SI, Blasi PR. Screening for colorectal cancer: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2021, 325:1978-98. 10.1001\/jama.2021.4417","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2021.09.075","article-title":"AGA clinical practice update on approach to the use of noninvasive colorectal cancer screening options: commentary","volume":"162","author":"Burke CA","year":"2022","unstructured":"Burke CA, Lieberman D, Feuerstein JD. AGA clinical practice update on approach to the use of noninvasive colorectal cancer screening options: commentary. Gastroenterology. 2022, 162:952-6. 10.1053\/j.gastro.2021.09.075","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000001122","article-title":"ACG clinical guidelines: colorectal cancer screening 2021","volume":"116","author":"Shaukat A","year":"2021","unstructured":"Shaukat A, Kahi CJ, Burke CA, Rabeneck L, Sauer BG, Rex DK. ACG clinical guidelines: colorectal cancer screening 2021. Am J Gastroenterol. 2021, 116:458-79. 10.14309\/ajg.0000000000001122","journal-title":"Am J Gastroenterol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1311194","article-title":"Multitarget stool DNA testing for colorectal-cancer screening","volume":"370","author":"Imperiale TF","year":"2014","unstructured":"Imperiale TF, Ransohoff DF, Itzkowitz SH, et al.. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014, 370:1287-97. 10.1056\/NEJMoa1311194","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310336","article-title":"Next-generation multitarget stool DNA test for colorectal cancer screening","volume":"390","author":"Imperiale TF","year":"2024","unstructured":"Imperiale TF, Porter K, Zella J, et al.. Next-generation multitarget stool DNA test for colorectal cancer screening. N Engl J Med. 2024, 390:984-93. 10.1056\/NEJMoa2310336","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-025-09595-7","article-title":"Factors associated with advanced adenoma detection by colonoscopy after negative multitarget stool DNA testing","author":"Ibrahim AM","year":"2025","unstructured":"Ibrahim AM, Saleem A, Faisal MS, Harris K, Fadel RA, Ibrahim MA, Suresh S. Factors associated with advanced adenoma detection by colonoscopy after negative multitarget stool DNA testing. Dig Dis Sci. 2025, 10.1007\/s10620-025-09595-7","journal-title":"Dig Dis Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0212-7","article-title":"Participant-related risk factors for false-positive and false-negative fecal immunochemical tests in colorectal cancer screening: systematic review and meta-analysis","volume":"113","author":"de Klerk CM","year":"2018","unstructured":"de Klerk CM, Vendrig LM, Bossuyt PM, Dekker E. Participant-related risk factors for false-positive and false-negative fecal immunochemical tests in colorectal cancer screening: systematic review and meta-analysis. Am J Gastroenterol. 2018, 113:1778-87. 10.1038\/s41395-018-0212-7","journal-title":"Am J Gastroenterol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2025.107654","article-title":"Multi-target stool DNA and the fecal immunochemical test: a systematic review and meta-analysis on test performances","volume":"69","author":"Ebner DW","year":"2025","unstructured":"Ebner DW, Johnson HA, Estes C, et al.. Multi-target stool DNA and the fecal immunochemical test: a systematic review and meta-analysis on test performances. Am J Prev Med. 2025, 69:107654. 10.1016\/j.amepre.2025.107654","journal-title":"Am J Prev Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2017.174","article-title":"Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer","volume":"112","author":"Rex DK","year":"2017","unstructured":"Rex DK, Boland CR, Dominitz JA, et al.. Colorectal cancer screening: recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017, 112:1016-30. 10.1038\/ajg.2017.174","journal-title":"Am J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/499257-stage-iv-rectal-adenocarcinoma-after-negative-multitarget-stool-dna-fecal-immunochemical-test-in-a-symptomatic-patient-misapplication-of-a-screening-test-in-a-diagnostic-context","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T14:35:48Z","timestamp":1781534148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/499257-stage-iv-rectal-adenocarcinoma-after-negative-multitarget-stool-dna-fecal-immunochemical-test-in-a-symptomatic-patient-misapplication-of-a-screening-test-in-a-diagnostic-context"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.110890","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,15]]}}}